ࡱ> q` pbjbjqPqP 1r::?.....D. "Yf/f/f/f/f/A0A0A0eXgXgXgXgXgXgX$Zh:]XQe>A0A0e>e>Xf/f/XEEEe>2f/f/eXEe>eXEEQSf/Z/ 쑈.@BRPVtX0"YR^A^0S^SPA04LE+8:A0A0A0XXCA0A0A0"Ye>e>e>e> "^,$ ^, RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, KARNATAKA, BANGALORE ANNEXURE II PROFORMA FOR REGISTRATION OF SUBJECTS FOR DISSERTATION 1.NAME OF CANDIDATE AND ADDRESSDr. RAVI CHETHAN KUMAR A N # 1, HOSTEL FOR PG & INTERNS BOYS, MMC & RI CAMPUS, MANDI MOHALLA, MYSORE 570 0012.NAME OF THE INSTITUTIONMysore Medical College and Research Institute, Mysore.3.COURSE OF STUDY AND SUBJECTM.D. (GENERAL MEDICINE)4.DATE OF ADMISSION TO COURSE03-05-20105.TITLE OF TOPICSTUDY OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE6. BRIEF RESUME OF THE INTENDED WORK: 6.1 Need for Study: Chronic obstructive pulmonary disease is characterized by airflow limitation that is not fully reversible. COPD is a major public health problem worldwide and is expanding throughout with a higher prevalence, morbidity and mortality. The World Health Report-2002 listed COPD as the 5th leading cause of death. It currently ranks No. 6 in global disease impact scale and is predicted to rise to No. 3 by 2020. The prevalence of COPD in India is 5% in males and 2.7% in females with male to female ratio of 1.6:1. It translates into approximately 12 million cases in India alone. COPD is a preventable and treatable disease with significant extra pulmonary effect that contribute to the morbidity and mortality. Systemic complication of COPD includes systemic inflammation, body weight loss, musculoskeletal effect, cardiovascular effects, hematological, neurological, psychiatric effect. The systemic complication reduces quality of life and increases mortality in COPD. Comorbid conditions are common in COPD and should be actively managed. The patients with COPD are at increased risk for cardiovascular events. This is attributed to increased systemic inflammation, which increases the risk of atherosclerosis and ischaemic heart disease. The decrease in cardiac reserve imposed by COPD may lead to greater hemodynamic compromise and greater risks of cardiovascular complication in acute myocardial infarction. Though COPD and ischaemic heart disease are seen as comorbidity in elderly, not many studies have been done to study clinical profile and impact of MI in association with COPD and its complications with pulmonary hypertension and corpulmonale. Hence the need for the study. 6.2 Review of Literature: 1. Number of studies have shown an association between COPD and selected cardiovascular disease endpoints including total cardiac mortality, mortality from acute myocardial infarction, mortality after coronary artery bypass graft and pulmonary embolism. Low FEV1 is associated with all cause mortality, cardiovascular disease mortality, non-fatal and fatal myocardial infarction, non-fatal and fatal stroke and atrial fibrillation. There are several reasons for COPD-Cardiovascular Disease Association, including a major shared risk factor (smoking) and a number of factor that may lead to increased stress on cardiovascular system.1 COPD patient especially in case of more advanced disease may manifest hypoxemia, may contribute to episode of ischemic cardiovascular disease (eg: angina, myocardial infarction, transient ischemic attack or stroke).1 2. COPD causes 5% of death in UK and may contribute to more cardiovascular disease and cerebrovascular disease. These are the leading cause of morbidity and mortality in high income countries together accounting for 27% of all deaths. Patients with COPD are at a high risk of hospitalization and death from cerebrovascular disease and cardiovascular disease and increased risk of diabetes mellitus.2 3. Tobacco use is the most important etiologic factor behind development of COPD. Cigarette smoking induces a state of systemic inflammation characterized by the intense interaction and accumulation of all capable of creating a marked oxidant antioxidant imbalance that result in cellular injury.3 Miller and Colleagues reported that number of circulating CD8+ T cells are increased and CD4+ T cells are decreased in heavy smokers. The abnormality was reversible often upon discontinuation of smoking. A low CD4+ / CD8+ ratio is characteristic of systemic inflammation in COPD.3 4. The neutrophilic inflammation of airway is an abnormal response to noxious particles and gases is the hallmark of COPD. The chronic inflammation involves airways, lung parenchyma, pulmonary vasculature activated inflammatory cells releases a variety of mediators including LTB4, IL8, TNF, TGF and many others and these causes systemic inflammation and other effects in distant organs.4 COPD is an important risk factor for atherosclerosis. COPD increases the risk of cardiovascular disease 2-3 fold. Even modest decrease in FEV1 causes 2-3 fold of IHD, stroke and sudden cardiac death.4 Neutrophillic inflammation that is the hallmark of COPD destabilize the atherosclerotic plaque and leads to rupture and increases the risk of myocardial infarction. 4 Polycythemia is a major hematological complications in patients with COPD pre disposing to vascular events. Hypoxia, hypercapnia and polycythemia together or alone leads to ischaemic events. 4 5. The co-morbidity of COPD with atherosclerotic disease associated with common risk factor such as smoking. However, atherosclerosis in addition shares many of the inflammatory mechanism with those found in COPD. 5 MediatorsTargetsCOPDAtherosclerosisTGFSmooth muscle cellsPeribronchial fibrosisIntimal hyperplasiaLTB4LeukocytesLeukocyte recruitment and ActivationLeukocyte recruitment and ActivationMMP9Extra cellular matrixEmphysemaPlaque rupture6. The exacerbation of COPD increases the risk of myocardial infarction and stroke. This may have implication for therapy and exacerbation of COPD. 6 7. COPD confers 2-3 fold greater risk of cardiovascular deaths. Which inturn accounts for half of all COPD deaths. A recent large epidemiological study showed increased cardiovascular mortality particularly in patients < 65 years old with COPD affecting long term prognosis after myocardial infarction. 7 COPD is a very strong predictor of hemodynamic compromise resulting in death or cardiogenic shock in patient presented with ST segment elevated MI. This study suggests that hemodynamic and pulmonary consequence of COPD. 6.3 Objectives of the Study: To study the clinical profile of Acute myocardial infarction in patients with chronic obstructive pulmonary disease. To study the risk factors and comorbid conditions for acute myocardial infarction associated with COPD patients. To study the inhospital outcome of acute phase of myocardial infarction in COPD patients. 7. MATERIALS AND METHODS: 7.1 Source of Data: Patients of COPD with acute myocardial infarction, who are admitted in K.R. Hospital Mysore and SJIC Mysore during the study period of November 2010-May 2013. 7.2 Method of Collection of Data: Sample size : Minimum of 30 Sampling method : Simple Random Sampling 7.3 Inclusion Criteria: 1. Known case of COPD patient with acute myocardial infarction. 2. Patients with clinically probable indicators of COPD with acute myocardial infarction. 3. Patient who meets the gold criteria for diagnosis of COPD with acute myocardial infarction. 7.4 Exclusion Criteria Patients with known case of asthma. COPD patients with old myocardial infarction. Patients with neuromuscular disease. Patients with restrictive lung disease. Data will be collected using a pretested proforma meeting the objectives of the study. Detailed history, physical examination and necessary investigations will be undertaken. The purpose of the study will be explained to the patient and informed consent obtained. The analysis of the data will be done using appropriate statistical methods. Ethical committee will be taken 7.5 Investigations: 1. Complete hemogram 2. RBS / FBS, PPBS 3. Lipid profile 4. Serum creatinine 5. Blood urea 6. ECG 7. 2-D echocardiography 8. Spirometry 9. Cardiac enzymes (trop-T) 7.6 Has Ethical Committee Clearance been obtained from your institution: Yes. (copy enclosed) 8. LIST OF REFERENCES: 1. Sidney S. Soral M. Quesenberry et al. COPD and incident cardiovascular disease hospitalization and mortality: Kaiser permanent medical care program. Chest /128/4 / October 2006: 2068-2074. 2. Feary RJ. Reed Rigvs CL. Smith JC. et al. prevalence of major comorbidities in subject with COPD and incidence of myocardial infarction and stroke. A comprehensive analysis using data from primary care. Thorax 2010:65:956-962. 3. Cote GC. Celli BR. Predictors of mortality in COPD. Clin chest med. 2007; 28:515- 524. 4. Khader AKA. Systemic effects of COPD. Pulmon. 2008; 9:3:2-4. 5. Magnus back, atherosclerosis COPD and chronic inflammation. Respiratory medicine: COPD update. Vol.4, issue 2, May 2008; 60-65. 6. Donaldson GC. Harst RJ. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest May 2010. Volume 137, 1091-1097. 7. Wakabayashi K. Gonzalez AM. Delhave C. et al. impact of COPD on acute phase outcome of myocardial infarction: Coronary Heart Disease; 18 January 2010. 8. Definition of COPD as in Global strategy for diagnosis, Management and prevention of Chronic Obstruction Pulmonary Disease. Updated 2009. 9. Definition of myocardial infarction as in joint ESC/ACC/AHA/WHF/WHO/ task force for redefinition of MI 2007. 9. Signature of the Candidate : 10. Remarks of the Guide : 11. Name and Designation of 11.1 Guide : DR. SHETTY SHIVAKUMAR M M.D. Professor, Department of Medicine, Mysore Medical College & Research Institute, Mysore. 11.2 Signature : 11.3 Head of the Department : DR. H VASUDEVA NAIK M.D. Professor and Head, Department of Medicine, Mysore Medical College & Research Institute, Mysore. 11.4 Signature : 12. 12.1 Remarks : 12.2 Remarks of the Dean and Director : 12.2 Signature : ETHICAL COMMITTEE CLEARANCE 1. Title of Dissertation : STUDY OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE" 2. Subject : M.D. GENERAL MEDICINE 3. Name of the Candidate : DR. RAVI CHETHAN KUMAR A N 4. Name of the Guide : DR. SHETTY SHIVAKUMAR M M.D. Professor, Department of Medicine, K.R. Hospital, Mysore Medical College & Research Institute, Mysore. 5. Approved / not approved (If not approved, suggestions) : MEMBERS OF THE ETHICAL CLEARANCE COMMITTEE PROFESSOR & HOD PROFESSOR & HOD DEPARTMENT OF SURGERY DEPARTMENT OF MEDICINE, MYSORE MEDICAL COLLEGE & MYSORE MEDICAL COLLEGE & RESEARCH INSTITUTE, RESEARCH INSTITUTE, MYSORE MYSORE SUPERINTENDENT SUPERINTENDENT K. R. HOSPITAL CHELUVAMBA HOSPITAL MYSORE MYSORE SUPERINTENDENT LAW EXPERT PKTB HOSPITAL MYSORE DEAN AND DIRECTOR PRINCIPAL MYSORE MEDICAL COLLEGE MYSORE MEDICAL COLLEGE & RESEARCH INSTITUTE & RESEARCH INSTITUTE MYSORE MYSORE From, Dr. RAVI CHETHAN KUMAR A N Post-graduate in General Medicine Department of General Medicine K.R. Hospital Mysore Medical College & Research Institute Mysore. To, Registrar (Evaluation) Rajiv Gandhi University of Health Sciences Bangalore. Through proper channel. Respected Sir, Subject: Submission of Synopsis titled STUDY OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE" I am hereby submitting the above titled synopsis (4 copies) as mentioned above, so kindly accept my application and do the needful. Thanking you, Yours faithfully, (Dr. ACP    4 k  = > ? @ j x M]  4}y}h[&h Uh2(VhYAh 8h h H*h  h}+j5>*hQh}+j5 h/OQ5 hp5hQhQ5hWzhph3-h}+j;h32h^:CJ h^:CJ h^:5\ h}+j5\ h}+j5CJ h}+j5h}+jh}+j5>*CJ"/ABCOP   r_kd$$IfTFaC"c    4 4 saT $Ifgd^: dh$Ifgd^:$G$If$a$ $dha$ p  4 k l o _kd$$IfTFaC"c    4 4 saT$G$If 7akd"$$IfTFaC"c    4 4 saT$G$If_kdl$$IfTFaC"c    4 4 saT ? @ f I ^ 9 $dha$gd Y$akd$$IfTFaC"c    4 4 saT$G$If#789<NR #GHIabc456̹̱̩̽̽̕؍̍̉hoBhh,Fh,ih ,hh|h\hh3hGhfhiRhIhWPhA hwYRhfkhwYRhwYRH*hwYRhjSh:>h}K h6zh}+j h}+j5>* h}+j5 hjS5h<3Ic6<$$Ifa$gdt&Dl $dha$gd Y >   = ? d r t !! ! ! !!S!V!{!8"9":";"######4#6#W#^#w######Ӽ㥩hNhhjhuOC h}+j5>* h'q5 h}+j5 h5hhMYhDhh'\I h'\Ih'\I h'\IhMYh[ht&DhghRhUzght&DhUzg5hU hwYRH*hwYRhwYRH*hRqQhB_hEh_Py2<>Hpmmmm$$Ifa$gdt&Dlykd$$Ifl\}  3 ~ tj 644 la > mmmm$$Ifa$gdt&DlykdZ$$Ifl\}  3 ~ tj 644 la> ? D Z d s mmmm$$Ifa$gdt&Dlykd$$Ifl\}  3 ~ tj 644 las t !;"#6##$w$$xka]OOO] & F 8gdNh dhgd'\I $dha$gd $dha$gd Yykd$$Ifl\}  3 ~ tj 644 la ###$v$w$$$$$$$C%D%H%d%f%v%%%%%%%%% & &&$&%&B&H&N&Y&[&f&g&&&&&&&&&&&&&&&&&'ļİ葍ЍhQha{Ih< 5 ha{I5>*hng+hShh_Y;hh_Yhh[hIhUN;hShe0XhSehehNhh}+jhm h) nh'qh'q5 h}+j5>* h}+j5huOChjhkQ6$$D%f%%%%%% &g&&&&&'4'Y''( & F 8dhgdNhgda{I 8`gdS `gdNh`` $dh`a$gd'q''4''((((( ) ) )) )!)")3)5)6)7)E)H)Y)[)\)f)g)n))))))))))**%*<*>*?*********++X+Y+++㬨h-3Yheh 0h o hy^H*hy^hihC hc5hkh2rUh4Kh:h8<huHk hcNhcNhcNh Dl h}+j5>* h}+j5h< h4h}+jh=WhQhJ~8((( ) )3)E)Y)g)n)))))))********gdk$a$gdcN dh^gdcN dh^gd4 $dh`a$********* *!*"*#*$*%*<**+@,,--5.. dhgdn dhgd-3Y dhgd2rUdhgd-3Ygdk+++++,:,;,?,@,C,,,,,,,,---\-]-q----- .4.5.7.8.Q......//-/3/4/5/6/7/8/:/X/_/`/y/~//踬謼Ȩ h8hfw h8h~7h8h~75hThch~7h@}haHJhIhAhnhZh{rh1HhWthhE3hcNh{h4h(hCh2rUh_h1h 0h5h-3Y6.4/5/6/7/8/9/:/Z/a/}/~///// 0+0,0?0$dh^a$gdg$dh^`a$gdg $dha$gd~7 gdC dhgd-3Y dhgd2rU/////////,0:0@0[0^0q0r0v0w000111/1013141<1C1Q1U1V1[1\1x11111111&2U2q2u22222S3ƿh8hu5H*h bh8h5 h5 h b5h8hu5 h8huh8hu5>* h8hghghuh8ha 75h3h8h~75h8h~75H* h35h8h85 h8h~72?0@0w000000011101A1B1U1V1W1X1Y1Z1[1\1x1 $dha$gdu$dh`a$gda 7 $dha$gd~7gdg$dh`a$gd~7x1y1z111222V2W2X22222233303U3V3W3X3Y3 $dha$gddh^`gddhgd $dha$gduS3T3Z3[3\3]3^3_33333V4x4444 5~555555)6@6w6666666666.7077777pppdpepfppκUh b h5 h b5hgh8hu5h8hu5>* h8h b h8hghu h8hu h8h?d0Y3Z3[3\3]3^3_33333334?4R4S4T4U4V4x4444444dhgdu $dha$gdu $dha$gdu444444 5:5h5{5|5}5~555555556$6%6)6@6k6dhgdu$dh`a$gdu $dha$gduk6v6w6666071777777pdpepfppppdhgdZ)Odhgd $dha$gdudhgduRAVI CHETHAN KUMAR A N) Forwarded to Dean and Director, MMC & RI, Mysore for further needful action Professor and Head, Date: Department of Medicine, Place: MMC & RI, Mysore /1h;0. A!"#$% $$If!vh555c#v#v#vc:V 555c/ / / / 4 4 sT$$If!vh555c#v#v#vc:V 555c/ / / / 4 4 sT$$If!vh555c#v#v#vc:V 555c/ / / / 4 4 sT$$If!vh555c#v#v#vc:V 555c/ / / / 4 4 sT$$If!vh555c#v#v#vc:V 555c/ / / / 4 4 sT$$If!vh555 5i #v#v#v #vi :Vl t0j 6,55 53 5~ $$If!vh555 5i #v#v#v #vi :Vl t0j 6,55 53 5~ $$If!vh555 5i #v#v#v #vi :Vl t0j 6,55 53 5~ $$If!vh555 5i #v#v#v #vi :Vl t0j 6,55 53 5~ 666666666vvvvvvvvv66666686666666666666666666666666666666666666666666666666hH666666666666666666666666666666666666666666666666666666666666666666D@D Normal*$CJ_HaJmH sH tH^@Qb^  Heading 3$ & F@&]^`5CJ\aJDA@D Default Paragraph FontVi@V 0 Table Normal :V 44 la (k@( 0No List 2O2 WW8Num2z0OJQJJOJ Absatz-StandardschriftartPOP WW-Absatz-Standardschriftart6O!6 WW8Num2z1 OJQJ^J2O12 WW8Num2z2OJQJDA@AD Default Paragraph FontNObN Heading x$CJOJPJQJ^JaJ6B@b6  Body Text x(/@ar( List^JH"@H Caption xx $6CJ]^JaJ.O. Index $^J<O< Table Contents $FOF Table Heading $ $a$5\n@n Uzg Table Grid7:V0*$?.r?.ABCOP4klo?A.! !!!!!> !}} }}Y}Y}}}4 ABCOP4klo?@fI^  9 Ic[ "6Mabgr*#/0IGH_`tu./xy| d!!!"##A$$$$$$$$$$$$%E%V%n%%%%%%%&+&I&j&k&}&~&&&&&&&&&&&&&&&&&/'u''''''' ((;(P(o(((((((((((((((() ) ) ).)^)))))))))*0*1*2*3*P*^*e*f*g*h**********++A+`+n+++++++++ ,,,,,4-5-D-a-b------!.A.00000000 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000 @0 @0 @0 @0 0 @0 @0 @0 @0 0 @0 @0 @0 @0 0 @0 @0 @0 @0 0000 0 0 0000000000000000 0 0 0 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000abgr| d!!$&&&/'A.K00а>P0,@ w K00 I00 P0,@ I00 P0,@ w K008K00K000K00K0 0 $tI0 0I0 0K0 0K008 #'+/S3p"$)+.03 <> s $(*.?0x1Y34k6p !#%&'(*,-/12456p8@0(  B S  ?TFG"H$M!I d"J"K 4""LMN< JO|P;Q"R S$T ,UVWlX,YZ t[4\]^컍_` la,b$c|$d<$edjfgh i  jgk<lgmlhnhoeTp tq0r s0t;uDOvܶwdox\y 4zl"{ |[|}#~ $ """"5ě? <"J LlQ"4 əԯX$G$A O l;  " 7755 n%n%u%}%%%0&0&7&?&b&b&A(A(F(V(V(](e(((^)^)e)m))))))))) * ***)*)*P*P*U*^*^***********`+`+e+++++++++--8.8.A.      !"#($%&')*+,-./1023457689:;<=@>?ABCDFEGHILJKMNOPQRS @@  :: t%|%%%%%6&>&F&F&h&h&E(N(N(\(d(l(l(((d)l))))))))))****#*/*/*T*]*]*d*d***********d+m+m+++++++++-->.>.A.  !"#%&'($)*+,-./1023457689:;<=?@>ABCDFEGHIKLJMNOPQRSVP*urn:schemas-microsoft-com:office:smarttagsplacehttp://www.5iantlavalamp.com/hQ*urn:schemas-microsoft-com:office:smarttagsCity0http://www.5iamas-microsoft-com:office:smarttags=R*urn:schemas-microsoft-com:office:smarttags PlaceType=T*urn:schemas-microsoft-com:office:smarttags PlaceNameBL*urn:schemas-microsoft-com:office:smarttagscountry-region xmTTRQPQPPLPLPLPQPTTRPQPTTRPQPTRPTTRPQPTTRTRQPQTTRPTRQPQPTRPQTTRPTTRQPQPTRPQPTTRPQPQPQNVEN%@K C E jv\h !6CMT grHPx~(0 !!!!!!""7#>#n%t%0&6&V(\(A.(  N R o u nkw !K!p!!!!!!!!a""""3#5#3$@$&& ))+ ,A.33333333333333333333333333 GHabXZ%-..//yy Z Z ] ] ^ ^ b c $!%!!!<""""g#h### $ $?$$$$$$'$'='t'P,[,e,f,t,,--A. GHabXZ%-..//yy Z Z ] ] ^ ^ b c $!%!!!<""""g#h### $ $?$$$$$$'$'='t'P,[,e,f,t,,--A. 1, +R.xDZ=J5N 8:$^`.88^8`OJQJ88^8`.88^8`.^`^`^`^`^`^`^`^`^` ^ `o(.  ^ `hH. L^`LhH. ^`hH. U^U`hH. %L^%`LhH. ^`hH. ^`hH. L^`LhH. ^ `o(.  ^ `hH. L^`LhH. ^`hH. U^U`hH. %L^%`LhH. ^`hH. ^`hH. L^`LhH.q^q`o(. A ^A `hH.  L^ `LhH. ^`hH. ^`hH. L^`LhH. Q^Q`hH. !^!`hH. L^`LhH.^`o(. } ^} `hH. M L^M `LhH. ^`hH. ^`hH. L^`LhH. ^`hH. ]^]`hH. -L^-`LhH. DZ=5N.x1, WW8Num1WW8Num2WW8Num3WW8Num4 fp        \        늯        *        gJ~=;)_6z < D m kG ;JuIqq<,i_p?dITv!H~!a"%$1$A$[&|':)ng+ ,3-/ 0hE3a 7~7t8^:UN;8<:>Ok@AYAoBuOCDt&DAFG&G1H WI'\Ia{I%'JaHJ4K6-K}KcNZ)OkQ/OQ"hQRqQwYRiRjS U2rU2(V4HV W=W]We0X Y-3YMYNQYh_Ya2Z ]y^ b;cUzgNhKiAj}+juHk Dl$m) n oq'qqsWtu!>u_PyCzWz){@}5T5c|QWPA'4 8nfwTfk1m !>SU B_x#yG?y{r4 i(ED}$Aq3VQCnLgAeej\CGR%~:>48\{l5f{lpid+sQwy:,FP1f\~%SegB[IZM[{33P4klo?@ "6MabgrA.333@--.R--L~~~~|-?.p@pp8@pp@@p@UnknownGz Times New Roman5Symbol3& z Arial?5 z Courier New;WingdingsG5  hMS Mincho-3 fg5& zaTahomaBAhޜ릢yX'SX'S24(.(.2QHP $PWz@RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, KARNATAKA, BANGALOREPelicanKrishna Prasad0         Oh+'0&$ <H h t  DRAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, KARNATAKA, BANGALOREPelicanNormalKrishna Prasad228Microsoft Office Word@x@△@0/@ޑX'G$Rt  bJ  ca."Systeman@ 9 -r@Times New Roman- >2 @i"`gRAJIV GANDHI UNIVERSITY OF HEALTH gfG7f$nffgn7$fg7f^gO7^g#nW$n^g^_n#- @ !# Oi--82 4`gSCIENCES, KARNATAKA, BANGALOREOg7^fg_N$$mfgff_gmg#$^fgnf_nf_- @ ! C- 2 4=`g L@Times New Roman- 2  `g - 2 r `g -@Times New Roman-2  `gANNEXURE IIHHHCHHHC'' 2 I `g 7 2 Z `g 6@Times New Roman-J2 A&*`gPROFORMA FOR REGISTRATION OF SUBJECTS FOR GT[G[TnTG[UTN[.ANTTN-[T[GATN;NTNAGZT2 A `gDISSERTATIONT.AANTNTN.[T 2  `g >- 2 `g --2 g1.2 2 ;g 2,2  gNAME OF CANDIDATE AND HH^CN<HHHH'IICCHHH2 %  gADDRESS1HHHHC88 2 %  g 2-2 (  4gDr. H,,2  4gRAVI CHETHAN KUMAR A NHHH'HNCCNHHMH_HHHH- 2 @ 4g .@Times New Roman-72 3 (  4g# 1, HOSTEL FOR PG & INTERNS E;;TTAGGGATNBT['TGGNTA.2 (  4gBOYS, MMC & RI CAMPUS, NTTAhhN[N'NThATA2 (  4gMANDI MOhTTT'hT2  4gHALLA,TTHGU 2 5 4g 5-2 (  4gMYSORE OhTATNG 2 +  4g;2 f  4g 570 001;:;;::- 2  4g 2- @ !|-- @ !-- @ !-- @ !x-- @ !-- @ !q-- @ !x -- @ ! -- @ !: -- @ !|4-- @ !4-- @ !V -- @ !V -- @ !V -- @ !V 4--2 g2.2 2 ;g 2.2  gNAME OF THE INSTITUTIONHH^CN<CNC'H8C'CHC'NH 2 )  g 2-)2 (  4gMYSORE MEDICAL COLLEYH8HC=Y=ICI<DI<<>2  4gGE AND 1H=HHH)2 l(  4gRESEARCH INSTITUTE, C=8=HCCHH8> =H>=2 l| 4gMYSORE.1YH8HC= 2 l6 4g 2- @ !|# -- @ !# -- @ !|# -- @ !q# -- @ !|# -- @ !:# -- @ !|# 4-- @ !^ -- @ !^ -- @ !^ -- @ !^ 4--2 g3.2 2 ;g 2)2  gCOURSE OF STUDY AND HNHH8CN<8CHHHHHH2 H gSUBJECT18HC2CHC 2 Hv g 1-.2 (  4gM.D. (GENERAL MEDICINE)YH!H=H=CI<Y=J!DH>! 2 + 4g 3- @ !|-- @ !-- @ !|-- @ !q-- @ !| -- @ !: -- @ !|4-- @ !^y-- @ !^y-- @ !^y -- @ !^y4--2 g4.2 2 ;g 2+2  gDATE OF ADMISSION TO HHCCN<HI^'88'MHCN2 " gCOURSEHNHH8C 2 "T g 2-2 (  4g0322 2   4g-! 2   4g02 2   4g52 2   4g-!2 2  4g20102222 2   4g 3- @ !|-- @ !-- @ !|-- @ !q-- @ !| -- @ !: -- @ !|4-- @ !S-- @ !S-- @ !S -- @ !S4--2 g5.2 2 ;g 2 2  gTITLE OF TOPICC'CCCN<CN<'H 2  g 2 2 (  4g22 Z  4gSTUDY OF 8CHHHN<2 i  4gACUTE HIHCC2   4gMYOCARDIAL ^HNHHHH'HC2 7(  4gINFA'H<I2 7  4gRCTION IN HHC'NH'H 2 7N  4gPATIENTS WITH <HD'CHC8d'CN)2 (  4gCHRONIC OBSTRUCTIVE HNHNH'HNC8CHHHC'HC%2 (  4gPULMONARY DISEASEV<HC^NIHHHH'8CI8C 2  4g2 2  4g 1- @ !|-- @ !-- @ !|-- @ !q-- @ !| -- @ !: -- @ !|4-- @ !Dh-- @ !-- @ !-- @ !-- @ !Dh-- @ !-- @ !q-- @ !Dh -- @ ! -- @ !: -- @ !Dh4-- @ !4-- @ !4--gg``ff__ee^^dd]]cc\\bb[[aaZZ``YY__XX ^ ^W W  ] ]V V  \ \U U  [ [T T  Z ZS S YYRRXXQQWWPPVVOOUUNN՜.+,0, hp  OMINCS(. ARAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, KARNATAKA, BANGALORE Title  !"#$%&'()*+,-./0123456789;<=>?@ACDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqstuvwxyz{|}~Root Entry F쑈Data :1TableB>^WordDocument1rSummaryInformation(r&DocumentSummaryInformation8CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q